Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

3.43
+0.11003.31%
Volume:1.64M
Turnover:5.57M
Market Cap:295.71M
PE:-0.91
High:3.52
Open:3.30
Low:3.27
Close:3.32
52wk High:19.11
52wk Low:3.05
Shares:86.21M
Float Shares:60.67M
Volume Ratio:0.78
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:1.78
PE(LYR):-1.08

Loading ...

EyePoint - Phase 3 Wet Amd Program Data Anticipated Beginning August 2026

THOMSON REUTERS
·
Jul 30

EyePoint - Topline Data for Dme Phase 3 Trials Anticipated in Q4 2027

THOMSON REUTERS
·
Jul 30

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of Duravyu™ for Treatment of Diabetic Macular Edema (Dme)

THOMSON REUTERS
·
Jul 30

Mizuho Raises Price Target on EyePoint Pharmaceuticals to $39 From $36, Keeps Outperform Rating

MT Newswires Live
·
Jul 29

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 29

Did EyePoint's (EYPT) Federal Settlement and 5‑Year Integrity Deal Just Reframe Its Risk Profile?

Simply Wall St.
·
Jul 28

Eyepoint Enters Settlement Agreement with DOJ, Oig-hhs, and DHA - SEC Filing

Reuters
·
Jul 18

EyePoint Pharmaceuticals Settles DEXYCU Case, Enhances Compliance Oversight

TIPRANKS
·
Jul 18

Eyepoint - to Pay $166,500 for Attorneys' Fees and Costs - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - Enters Corporate Integrity Agreement with Oig-hhs on July 13, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - to Pay $4.68 Mln Plus Interest in Settlement - SEC Filing

THOMSON REUTERS
·
Jul 18

Eyepoint - Enters Settlement Agreement with DOJ, Oig-hhs, and Dha on July 17, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 18

EyePoint to pay $4.6M to resolve False Claim Act allegations

TIPRANKS
·
Jul 17

Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target

MT Newswires Live
·
Jul 16

Eyepoint Grants Inducement Stock Options for 63,500 Shares at $13.85 Each

Reuters
·
Jul 16

Eyepoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 16

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 16

Eyepoint Inc : Stifel Initiates Coverage with Buy Rating; Target Price $40

THOMSON REUTERS
·
Jul 16

Eyepoint Pharmaceuticals Initiated at Buy by Stifel

Dow Jones
·
Jul 16

EyePoint initiated with a Buy at Stifel

TIPRANKS
·
Jul 16